111605-04-0

Basic information

• Product Name: 2H-1-Benzazepin-2-one, 1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-
• CAS NO: 111605-04-0
• Molecular Formula: C21H22F3NO2
• Molecular Weight: 377.406
• Mol File: 111605-04-0.mol

Chemical Properties

• CAS DataBase Reference: 2H-1-Benzazepin-2-one, 1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-1-Benzazepin-2-one, 1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-(111605-04-0)
• EPA Substance Registry System: 2H-1-Benzazepin-2-one, 1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-(111605-04-0)

Safety Data

• Hazardous Substances Data: 111605-04-0(Hazardous Substances Data)

Upstream product

• 138573-57-6 (3S,4R)-4-(4-Methoxy-phenyl)-2-oxo-3-propyl-6-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 6656-49-1 2-methyl-1-nitro-3-(trifluoromethyl)benzene 
• 111604-99-0 [1-(4-Methoxyphenyl)-2-[2-nitro-6-(trifluoromethyl)phenyl]ethyl]propanedioic acid,dimethyl ester 
• 138573-31-6 2-[1-(4-Methoxy-phenyl)-2-(2-nitro-6-trifluoromethyl-phenyl)-ethyl]-2-propyl-malonic acid dimethyl ester 
• 138573-43-0 2-[2-(2-Amino-6-trifluoromethyl-phenyl)-1-(4-methoxy-phenyl)-ethyl]-2-propyl-malonic acid dimethyl ester 
• 7443-25-6 dimethyl 2-(4-methoxybenzylidene)malonate 
• 138573-57-6 (3S,4S)-4-(4-Methoxy-phenyl)-2-oxo-3-propyl-6-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-3-carboxylic acid methyl ester 
• 111604-75-2 (cis)-1-[2-(Dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-(2-propenyl)-6-(trifluoromethyl)2H-1-benzazepin-2-one 

Downstream Products

• 111605-28-8 (cis)-1-[2-(Dimethylamino)ethyl]-1,3,4,5-tetrahydro-4-(4-methoxyphenyl)-3-propyl-6-(trifluoromethyl)-2H-1-benzazepin-2-one, monohydrochloride 
• 119217-14-0 (3S,4S)-1-(2-Dimethylamino-ethyl)-4-(4-methoxy-phenyl)-3-propyl-6-trifluoromethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one 

Relevant articles and documents

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site

We have synthesized a series of benzazepinones (2) in order to determine the structure-activity relationships (SAR) for calcium channel blockers related to diltiazem. A prerequisite for calcium channel blocking activity in vitro and in vivo is the presenc

Benzazepinone Calcium Channel Blockers. 3. Synthesis and Structure-Activity Studies of 3-Alkylbenzazepinones

As part of a program aimed at identifying novel analogues of diltiazem, we developed several synthetic routes for 3-alkylbenzazepinones, both in racemic and nonracemic form.Structure-activity relationship studies in this series have led to identification

Benzazepine derivatives

Vasodilating activity is exhibited by compounds having the formula STR1 and pharmaceutically acceptable salts thereof.